Sort
17,288 grants matching “multiple sclerosis”
Events Leading to Loss Of Tolerance to Myelin Basic Pro*
$227,400University Of Washington · R21 · FY2003 · AI
CNS REMYELINATION BY GENETICALLY-MODIFIED T CELLS
$227,282Cleveland Clinic Foundation · R01 · FY2001 · NS
Mutation selection for immune response to MBP in HAM/TSP
$227,250University Of Vermont &St Agric College · R21 · FY2003 · AI
IFN GAMMA GENE REGULATION IN T CELLS AND NK CELLS
$227,250Vanderbilt University · R01 · FY2001 · AI
CD200 Expression on Apoptotic DCs and Immune Tolerance
$227,250Medical College Of Wisconsin · R21 · FY2004 · HL
Light-based regulation of autophagy processing to target pathological forms of tau
$227,250Jason P Weick · University Of New Mexico Health Scis Ctr · R21 · FY2017 · NS
Probing antigen specificity and response of autoimmune B cells in Neuromyelitis Optica
$227,250Brandon James Dekosky · University Of Kansas Lawrence · R21 · FY2019 · AI
CD200 Expression on Apoptotic DCs and Immune Tolerance
$227,250Medical College Of Wisconsin · R21 · FY2005 · HL
MODULATION OF AUTOREACTIVE T CELLS
$227,213University Of Tennessee Knoxville · R01 · FY2000 · NS
Role of B7H4 and CD48 in EAE
$227,211Brigham And Women'S Hospital · P01 · FY2005 · AI
Deep Learning Reconstruction for Rapid Multi-Component Relaxometry
$227,198Fang Liu · Massachusetts General Hospital · R21 · FY2022 · EB
Arsenate resistance in prokaryotes and eukaryotes
$227,147Barry P. Rosen · Wayne State University · R01 · FY2008 · GM
MECHANISMS OF LOW PHYSICAL WORK CAPACITY, FATIGUE, AND REDUCED MOBILITY IN MULTIPLE SCLEROSIS
$227,133University Of Illinois · · FY2018 · Defense Health Agency
In vivo effects of anthrax toxins:imaging host response & bacterial proliferation
$227,043Ian Justin Glomski · University Of Virginia · R21 · FY2009 · AI
Influence of Brain Inflammation on the Occurrence of Embolic Stroke
$227,000Svetlana M Stamatovic · University Of Michigan At Ann Arbor · R21 · FY2016 · NS
Metabolic dysregulation and therapeutic intervention in asthma
$226,950Ruoning Wang · Research Inst Nationwide Children'S Hosp · R21 · FY2016 · AI
Preclinical development of a novel Nrf2-activator formulation for the treatment of idiopathic pulmonary fibrosis
$226,805Louise Hecker · University Of Arizona · R21 · FY2018 · AG
Vasoactive intestinal peptide for the treatment of psoriasis
$226,765Sandra Reichstetter · Pharmain Corporation · R43 · FY2012 · AI
Immunoassay and Imaging Core
$226,642Stuart P Weisberg · Columbia University Health Sciences · U19 · FY2023 · AI
Transcriptional regulations of effector and regulatory T cells in EAE
$226,557Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2014 · NS
Molecular Analysis of Effector and Regulatory T cell Responses in MS
$226,557Howard L Weiner · Brigham And Women'S Hospital · P01 · FY2014 · NS
NEUROPATHOLOGY
$226,527Matthew P Frosch · Massachusetts General Hospital · P50 · FY2010 · AG
The pathogenic role of protein aggregation in inflammatory demyelination
$226,500Oscar A Bizzozero · University Of New Mexico Health Scis Ctr · R21 · FY2013 · NS
Post-transcriptional Regulation of Cytokine Production
$226,500Mingui Fu · University Of Missouri Kansas City · R21 · FY2015 · AI
MULTIPLE SCLEROSIS AS A NONCANONICAL TAUOPATHY
$226,500East Carolina University · · FY2022 · Defense Health Agency